|
1
|
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.
|
Lancet
|
2009
|
5.32
|
|
2
|
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.
|
Lancet
|
2009
|
4.07
|
|
3
|
Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines.
|
Eur J Pediatr
|
2009
|
2.80
|
|
4
|
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells.
|
Blood
|
2008
|
2.44
|
|
5
|
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries.
|
Medicine (Baltimore)
|
2010
|
2.33
|
|
6
|
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications.
|
J Exp Med
|
2003
|
2.19
|
|
7
|
Challenges in infant immunity: implications for responses to infection and vaccines.
|
Nat Immunol
|
2011
|
2.17
|
|
8
|
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination.
|
J Immunol
|
2002
|
1.98
|
|
9
|
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
|
Blood
|
2007
|
1.85
|
|
10
|
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants.
|
J Pediatr
|
2007
|
1.77
|
|
11
|
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study.
|
Arthritis Rheum
|
2011
|
1.67
|
|
12
|
Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses.
|
J Immunol
|
2012
|
1.59
|
|
13
|
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.
|
J Immunol
|
2008
|
1.49
|
|
14
|
Can successful vaccines teach us how to induce efficient protective immune responses?
|
Nat Med
|
2005
|
1.48
|
|
15
|
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.
|
Nat Med
|
2010
|
1.45
|
|
16
|
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type.
|
Vaccine
|
2004
|
1.36
|
|
17
|
Impaired antibody response causes persistence of prototypic T cell-contained virus.
|
PLoS Biol
|
2009
|
1.31
|
|
18
|
Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy.
|
J Infect Dis
|
2010
|
1.27
|
|
19
|
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
|
Clin Infect Dis
|
2008
|
1.26
|
|
20
|
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety.
|
Am J Public Health
|
2004
|
1.15
|
|
21
|
How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
|
Pediatrics
|
2005
|
1.13
|
|
22
|
Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival.
|
J Immunol
|
2006
|
1.12
|
|
23
|
Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan.
|
Trop Med Int Health
|
2006
|
1.11
|
|
24
|
Use of pneumococcal polysaccharide vaccine in children: what is the evidence?
|
Curr Opin Infect Dis
|
2012
|
1.09
|
|
25
|
Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant.
|
PLoS One
|
2008
|
1.08
|
|
26
|
Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens.
|
J Immunol
|
2003
|
1.08
|
|
27
|
Glycoconjugate vaccines and immune interference: A review.
|
Vaccine
|
2010
|
1.07
|
|
28
|
Acceptability of maternal immunization against influenza: the critical role of obstetricians.
|
J Matern Fetal Neonatal Med
|
2012
|
1.06
|
|
29
|
Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis.
|
Infect Immun
|
2002
|
1.05
|
|
30
|
Vaccination during pregnancy to protect infants against influenza: why and why not?
|
Vaccine
|
2011
|
1.05
|
|
31
|
Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infants.
|
J Infect Dis
|
2006
|
1.04
|
|
32
|
Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience.
|
Ageing Res Rev
|
2010
|
1.03
|
|
33
|
Booster vaccination after neonatal priming with acellular pertussis vaccine.
|
J Pediatr
|
2010
|
1.02
|
|
34
|
Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic mice.
|
J Immunol
|
2004
|
1.00
|
|
35
|
Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice.
|
Infect Immun
|
2002
|
0.99
|
|
36
|
Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants.
|
J Immunol
|
2012
|
0.99
|
|
37
|
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog.
|
J Control Release
|
2012
|
0.98
|
|
38
|
The next decade of vaccines: societal and scientific challenges.
|
Lancet
|
2011
|
0.97
|
|
39
|
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells.
|
PLoS One
|
2009
|
0.96
|
|
40
|
Neonatal immunization: where do we stand?
|
Curr Opin Infect Dis
|
2011
|
0.95
|
|
41
|
Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell niche.
|
J Immunol
|
2012
|
0.95
|
|
42
|
Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory?
|
Vaccine
|
2010
|
0.95
|
|
43
|
Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection.
|
J Infect Dis
|
2002
|
0.95
|
|
44
|
Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells.
|
Eur J Immunol
|
2008
|
0.95
|
|
45
|
Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn.
|
Pediatr Infect Dis J
|
2013
|
0.93
|
|
46
|
Mode of action of adjuvants: implications for vaccine safety and design.
|
Biologicals
|
2010
|
0.89
|
|
47
|
The advantage of mucosal immunization for polysaccharide-specific memory responses in early life.
|
Eur J Immunol
|
2005
|
0.89
|
|
48
|
Vaccine safety controversies and the future of vaccination programs.
|
Pediatr Infect Dis J
|
2005
|
0.89
|
|
49
|
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children.
|
Vaccine
|
2011
|
0.89
|
|
50
|
CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles.
|
Virology
|
2003
|
0.88
|
|
51
|
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.
|
Pharmacogenomics
|
2011
|
0.87
|
|
52
|
Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy.
|
Eur J Immunol
|
2006
|
0.87
|
|
53
|
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium).
|
Vaccine
|
2003
|
0.86
|
|
54
|
Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheres.
|
J Immunol
|
2004
|
0.86
|
|
55
|
Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.
|
Pediatr Infect Dis J
|
2013
|
0.85
|
|
56
|
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients.
|
Haematologica
|
2011
|
0.85
|
|
57
|
Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers.
|
J Immunol
|
2003
|
0.85
|
|
58
|
Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
|
J Virol
|
2007
|
0.85
|
|
59
|
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?
|
Clin Vaccine Immunol
|
2006
|
0.84
|
|
60
|
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate.
|
Vaccine
|
2003
|
0.84
|
|
61
|
CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal mice.
|
Vaccine
|
2003
|
0.84
|
|
62
|
Proximal splenic artery embolization for blunt splenic injury: clinical, immunologic, and ultrasound-Doppler follow-up.
|
J Trauma
|
2007
|
0.84
|
|
63
|
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland.
|
Pediatr Infect Dis J
|
2009
|
0.83
|
|
64
|
Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events.
|
J Pediatr
|
2004
|
0.83
|
|
65
|
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys.
|
Am J Trop Med Hyg
|
2004
|
0.83
|
|
66
|
Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccines.
|
Eur J Immunol
|
2002
|
0.83
|
|
67
|
Recurrence of cardiorespiratory events following repeat DTaP-based combined immunization in very low birth weight premature infants.
|
J Pediatr
|
2008
|
0.81
|
|
68
|
Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization.
|
J Pediatr
|
2008
|
0.81
|
|
69
|
Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition?
|
Arch Neurol
|
2011
|
0.81
|
|
70
|
Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measures.
|
Scand J Infect Dis
|
2010
|
0.81
|
|
71
|
Atorvastatin treatment and vaccination efficacy.
|
J Clin Pharmacol
|
2007
|
0.81
|
|
72
|
Memory B cell compartment constitution and susceptibility to recurrent lower respiratory tract infections in young children.
|
J Leukoc Biol
|
2013
|
0.81
|
|
73
|
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients.
|
Oncologist
|
2012
|
0.81
|
|
74
|
Comparison of clinical presentation of respiratory tract infections in H1N1/09-positive and H1N1/09-negative patients.
|
Eur J Pediatr
|
2011
|
0.80
|
|
75
|
Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticles.
|
Bioconjug Chem
|
2011
|
0.80
|
|
76
|
Tetanus immunity as a surrogate for past diphtheria-tetanus-pertussis immunization in migrant children.
|
Pediatr Infect Dis J
|
2013
|
0.79
|
|
77
|
Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responses.
|
Vaccine
|
2004
|
0.79
|
|
78
|
The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703.
|
FEMS Immunol Med Microbiol
|
2005
|
0.78
|
|
79
|
Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005.
|
Vaccine
|
2007
|
0.78
|
|
80
|
Improvement of measles immunity among migrant populations: lessons learned from a prevalence study in a Swiss prison.
|
Swiss Med Wkly
|
2011
|
0.77
|
|
81
|
Vaccine-induced immunity in children after orthotopic liver transplantation: a 12-yr review of the Swiss national reference center.
|
Pediatr Transplant
|
2007
|
0.77
|
|
82
|
Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland.
|
Clin Vaccine Immunol
|
2012
|
0.77
|
|
83
|
Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infection.
|
Microbes Infect
|
2004
|
0.77
|
|
84
|
Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theories.
|
Vaccine
|
2009
|
0.76
|
|
85
|
Immunization and transplantation--what is new and what is coming?
|
Pediatr Transplant
|
2008
|
0.76
|
|
86
|
Comment on "Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature".
|
J Immunol
|
2009
|
0.75
|
|
87
|
Protective antibody responses to influenza A/H1N1/09 vaccination in children with celiac disease.
|
J Pediatr Gastroenterol Nutr
|
2012
|
0.75
|
|
88
|
[Immunization and immuno-modulation for prevention of respiratory tract infections].
|
Rev Med Suisse
|
2005
|
0.75
|
|
89
|
Attitudes of Swiss Health Care Providers Towards Childhood Immunizations.
|
Pediatr Infect Dis J
|
2016
|
0.75
|
|
90
|
Enhanced chickenpox exanthema in vaccine injection site.
|
Scand J Infect Dis
|
2006
|
0.75
|
|
91
|
[Immunization guidelines in patients with chronic liver diseases].
|
Rev Med Suisse
|
2007
|
0.75
|
|
92
|
[Vaccinology, a new science at odds with beliefs].
|
Rev Med Suisse
|
2005
|
0.75
|